Voriconazole potentiates warfarin‐induced prothrombin time prolongation

200381 citationsJournal Articlebronze Open Access

Authors

Lynn Purkins · Pfizer (United Kingdom)

Nolan Wood · Pfizer (United Kingdom)

Diane Kleinermans · Pfizer (Belgium)

D. J. Nichols · Pfizer (United Kingdom)

Abstract

Coadministration of voriconazole and warfarin potentiates warfarin-induced prothrombin time prolongation. Regular monitoring of prothrombin time is recommended if these drugs are coadministered, with appropriate adjustment of the dose of warfarin.

Topics & Keywords

Antifungal resistance and susceptibility Oral microbiology and periodontitis research Inflammatory mediators and NSAID effects

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: British Journal of Clinical Pharmacology

Volume 56, Issue s1, pp. 24-29

DOI: 10.1046/j.1365-2125.2003.01995.x

Field-Weighted Citation Impact: 3.75